Delivery Order SPE2DB22D3016-SPE2DB25FAUS4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,183.76 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This firm fixed-price contract, awarded on September 4, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $26,992.64 firm fixed price delivery order for 100 mg vials of Remicade, a pharmaceutical product used to treat inflammatory conditions. This non-set-aside contract was awarded competitively on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a child order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $17,318.52 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and reflects the agency's ongoing pharmaceutical supply needs for military healthcare operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,366.24 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.28 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,155.03 for 100 mg vials of Remicade on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a $15,359.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of September 22, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor and represents a continuation of AmerisourceBergen's role as a critical supplier of pharmaceutical products to the federal healthcare system. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials under a firm fixed price arrangement. The contract, valued at $7,518.30, was executed on May 20, 2025, with an ultimate completion date of May 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,032.89 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract, awarded September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $5,012.20 to supply 100 mg vials of Remicade, a biologic immunosuppressant medication used to treat autoimmune conditions. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAUS4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,183.23 to AmerisourceBergen Drug Corp for 100 mg vials of Remicade, a biologic medication commonly used to treat inflammatory conditions. This non-set-aside contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The delivery order employs firm fixed price terms and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's substantial federal contract portfolio demonstrates its role as a critical vendor for federal medical procurement, regularly supplying pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 4/24/25 |